Clinical Trials Directory

Trials / Completed

CompletedNCT02811718

Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine, whether the 3RP is feasible, accepted and efficacious and durable when delivered via Skype to patients with neurofibromatosis type 2 (NF2) who are deaf or have severe hearing loss using Communication Access Realtime Translation (CART) and/or American Sign Language (ASL). This will be a substudy of the IRB-approved protocol #2013P002605. It is the same study except it is looking at a particular sub-population: patients with NF2 who are hard of hearing.

Conditions

Interventions

TypeNameDescription
BEHAVIORALStress Management Group 1Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.
BEHAVIORALStress Management Group 2Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.

Timeline

Start date
2016-07-01
Primary completion
2018-06-01
Completion
2018-07-01
First posted
2016-06-23
Last updated
2018-08-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02811718. Inclusion in this directory is not an endorsement.